ESPR Earnings

ESPR reported its earnings on 2026-03-10, showcasing a revenue of 168.45M against an estimate of 160.58M, resulting in a 4.9% surprise. The EPS was 0.22, surpassing the expected 0.23 by -4.35%. The stock experienced a -11.18% price change on the earnings day and a -19.74% change over the next five days, reflecting market reactions to the results.

Following ESPR's earnings announcement on 2026-03-10, the stock price moved by -11.18% on the day of the release. Over the subsequent five days, it saw a -19.74% change. Historically, ESPR's stock price tends to shift by an average of -1.72% in the 10 days leading up to earnings and 0.14% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ESPR's annual revenue to reach 109.49M, while the EPS is projected at -0.01. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ESPR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ESPR's stock price typically moves by -1.72% in the 10 days before its earnings and 0.14% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.01 and revenue of 109.49M.

The earnings call reveals strong financial performance with significant revenue growth, a positive outlook with expected benefits from new guidelines, and strategic market expansion. The Q&A session shows confidence in overcoming competitive risks and highlights potential gains from the triple combination therapy. Although management was vague about some timelines, the overall sentiment, driven by strong revenue, optimistic guidance, and market expansion, suggests a positive stock price movement.